Prevalence of fibrosis and steatosis determined by transition elastography and controlled attenuation parameter (fibroscanâ) in diabetic patients

Prevalence of fibrosis and steatosis determined by transition elastography and controlled attenuation parameter (fibroscanâ) in diabetic patients

Introduction and Objective: Younossi ZM et al.have recently reported a higher prevalence of fatty liver disease associated with metabolic dysfunction (MAFLD) in diabetics (55.5%) versus the general population (25%); however, in Mexico, the prevalence of steatosis and fibrosis related to MAFLD in pat...

Full description

Bibliographic Details
Main Authors: A Burak-Leipuner, F García-Gorrosquieta, N Uribe-Rivera, A Servín-Caamaño, JA Romero-Bermúdez, LE Ceceña-Martínez, P Alagón-Fernández del Campo, FY Vargas-Duran, AK Soto-Martinez, CI Hinojosa-Segura, D Montemira-Orozco, JL Perez-Hernández, G Alexanderson-Rosas, F Higuera-de la Tijera
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268122001314

Internet

http://www.sciencedirect.com/science/article/pii/S1665268122001314

Similar Items